A chemical genomics approach to drug reprofiling in oncology: Antipsychotic drug risperidone as a potential adenocarcinoma treatment
Structure of the D2 dopamine receptor bound to the atypical antipsychotic drug risperidone
Tags: antipsychotic, bipolar disorder, D-amino acid oxidase inhibitor, dopamine antagonist, Risperdal®, schizophrenia, serotonin antagonist
BASi Method Number SAP.1417
Sign up and you’ll receive the latest updates that matter to you, delivered straight to your inbox.
